When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KTOV - Kitov Pharma updates on NT-219 clinical program
Kitov Pharma Ltd.
Kitov Pharma (KTOV+5.6%) announces plans to expand the Phase 1/2 clinical trial of NT-219 with cetuximab trial in patients with recurrent or metastatic head and neck cancer to also include evaluation of NT-219 as monotherapy treatment in patients with advanced solid tumors.
More news on: Kitov Pharma Ltd, Healthcare stocks news,